GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » EV-to-FCF

Pharmaresearch Bio Co (XKRX:217950) EV-to-FCF : 29.71 (As of May. 29, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Pharmaresearch Bio Co's Enterprise Value is ₩98,428 Mil. Pharmaresearch Bio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₩3,313 Mil. Therefore, Pharmaresearch Bio Co's EV-to-FCF for today is 29.71.

The historical rank and industry rank for Pharmaresearch Bio Co's EV-to-FCF or its related term are showing as below:

XKRX:217950' s EV-to-FCF Range Over the Past 10 Years
Min: -32.66   Med: 29.61   Max: 244.85
Current: 29.53

During the past 6 years, the highest EV-to-FCF of Pharmaresearch Bio Co was 244.85. The lowest was -32.66. And the median was 29.61.

XKRX:217950's EV-to-FCF is ranked worse than
71.62% of 370 companies
in the Biotechnology industry
Industry Median: 8.835 vs XKRX:217950: 29.53

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-29), Pharmaresearch Bio Co's stock price is ₩28700.00. Pharmaresearch Bio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩569.000. Therefore, Pharmaresearch Bio Co's PE Ratio for today is 50.44.


Pharmaresearch Bio Co EV-to-FCF Historical Data

The historical data trend for Pharmaresearch Bio Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co EV-to-FCF Chart

Pharmaresearch Bio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial -17.84 90.43 33.94 29.41 19.17

Pharmaresearch Bio Co Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF Get a 7-Day Free Trial -17.84 90.43 33.94 29.41 19.17

Competitive Comparison of Pharmaresearch Bio Co's EV-to-FCF

For the Biotechnology subindustry, Pharmaresearch Bio Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaresearch Bio Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaresearch Bio Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Pharmaresearch Bio Co's EV-to-FCF falls into.



Pharmaresearch Bio Co EV-to-FCF Calculation

Pharmaresearch Bio Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=98428.077/3312.558
=29.71

Pharmaresearch Bio Co's current Enterprise Value is ₩98,428 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pharmaresearch Bio Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was ₩3,313 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaresearch Bio Co  (XKRX:217950) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pharmaresearch Bio Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=28700.00/569.000
=50.44

Pharmaresearch Bio Co's share price for today is ₩28700.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Pharmaresearch Bio Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₩569.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Pharmaresearch Bio Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaresearch Bio Co (XKRX:217950) Business Description

Traded in Other Exchanges
N/A
Address
641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co (XKRX:217950) Headlines

No Headlines